Comparison of the Clinical Outcomes of Patients With Positive Xpert Carba-R Tests for Carbapenemase-Producing Enterobacterales According to Culture Positivity.

Hyeonji SeoJeong-Young LeeSeung Hee RyuSun Hee KwakEun Ok KimSeongman BaeMin Jae KimYong Pil ChongSung Han KimSang-Oh LeeSang-Ho ChoiHeungsup SungMi-Na KimYang Soo KimJiwon Jung

Published in: Open forum infectious diseases (2022)

Our study suggests that XPCN patients had lower rates of both infection and transmission than XPCP patients. The Xpert Carba-R assay is clinically useful not only for rapid identification of CPE but also for predicting risks of infection and transmission when performed along with culture.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
escherichia coli
cystic fibrosis
multidrug resistant
klebsiella pneumoniae
gram negative